Long-term lithium treatment of bipolar disorder influences very small embryonic-like stem cells and mRNA expression of pluripotency and glial markers

Author(s):  
Ewa Ferensztajn
2017 ◽  
Vol 27 ◽  
pp. S813
Author(s):  
E. Ferensztajn-Rochowiak ◽  
J. Kucharska-Mazur ◽  
M. Tarnowski ◽  
J. Samochowiec ◽  
M.Z. Ratajczak ◽  
...  

2016 ◽  
Vol 18 (1) ◽  
pp. 54-62 ◽  
Author(s):  
Ewa Ferensztajn-Rochowiak ◽  
Jolanta Kucharska-Mazur ◽  
Jerzy Samochowiec ◽  
Mariusz Z. Ratajczak ◽  
Michal Michalak ◽  
...  

2016 ◽  
Vol 26 (9) ◽  
pp. 1516-1521 ◽  
Author(s):  
Ewa Ferensztajn-Rochowiak ◽  
Maciej Tarnowski ◽  
Jerzy Samochowiec ◽  
Michal Michalak ◽  
Mariusz Z. Ratajczak ◽  
...  

2016 ◽  
Vol 68 (5) ◽  
pp. 1042-1045 ◽  
Author(s):  
Ewa Ferensztajn-Rochowiak ◽  
Maciej Tarnowski ◽  
Jerzy Samochowiec ◽  
Michal Michalak ◽  
Mariusz Z. Ratajczak ◽  
...  

2017 ◽  
Vol 41 (S1) ◽  
pp. S206-S206
Author(s):  
J. Kucharska-Mazur ◽  
A. Reginia ◽  
M. Jabłoński ◽  
B. Dołęgowska ◽  
J. Rybakowski ◽  
...  

IntroductionAfter analysis of biological and pharmacological data, we formulated the hypothesis that the factors involved in trafficking of stem cells could be engaged in aetiology of bipolar disorder (BP).AimsIn this study, we considered the role of complement cascade proteins, stromal derived factor-1 (SDF-1), and sphingosine-1-phosphate (S1P) in long-term treated BP.MethodsA group of 30 patients with BP, without the history of lithium treatment, was examined in remission and compared with a group of 30 healthy volunteers. In peripheral blood, we have analysed the concentration of stromal derived factor-1 (SDF-1), sphingosine-1-phosphate (S1P), and some proteins of the complement cascade (C3a, C5a, C5b-9).ResultsPeripheral blood concentration of C3a, C5a, C5b-9 and SDF-1 was significantly higher in BP group compared to control group. The concentration of S1P does not distinguish BP patients from controls.ConclusionOur results suggest the possible role of the regeneration system in aetiology of BP.This work was supported by grant POIG.01.01.02-00-109/09.Disclosure of interestThe authors have not supplied their declaration of competing interest.


2021 ◽  
Vol 281 ◽  
pp. 228-234
Author(s):  
R. Queissner ◽  
M. Lenger ◽  
A. Birner ◽  
N. Dalkner ◽  
F. Fellendorf ◽  
...  

2007 ◽  
Vol 195 (3) ◽  
pp. 357-367 ◽  
Author(s):  
Kaan Yucel ◽  
Margaret C. McKinnon ◽  
Valerie H. Taylor ◽  
Kathryn Macdonald ◽  
Martin Alda ◽  
...  

2021 ◽  
pp. 1-25
Author(s):  
Ewa Ferensztajn-Rochowiak ◽  
Ewa Kurczewska ◽  
Błażej Rubiś ◽  
Michalina Lulkiewicz ◽  
Hanna Hołysz ◽  
...  

Abstract Objectives: Bipolar disorder (BD) may be connected with accelerated aging, the marker of this can be shorter telomere length (TL). Some data suggest that lithium may exert a protective effect against telomere shortening. The study aimed to compare the telomere length between patients with bipolar disorder and control subjects. The effect of long-term lithium treatment was also assessed. Methods: The study group comprised 41 patients with BD, including 29 patients treated longitudinally with lithium (mean 16.5 years) and 20 healthy people. Telomere length was assessed by the quantitative polymerase chain reaction (qPCR). Results: In the control group, the TL was significantly longer in males than in females. Male bipolar patients had significantly shorter TL compared with the control male group. In bipolar patients, there was no correlation between TL and duration of treatment. The TL was negatively correlated with age in male bipolar patients. Conclusion: The study did not confirm the lithium effect on TL in bipolar patients. TL showed gender differences, being shorter in BD males, compared to control males, and longer in healthy males, compared to control females.


Sign in / Sign up

Export Citation Format

Share Document